Skip to main content

Advertisement

Table 1 Comparison of HPV type-specific prevalence among HPV-positive women from the general population and with ICC

From: Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria

HPV type General Population
(N = 245)
ICC
(N = 68)
 
  n (%, 95% CI) n (%, 95% CI) Prevalence ratio
(95% CI)
16 30 (12.2, 8.4 - 17.0) 46 (67.6, 55.2 - 78.5) 5.5 (3.7-8.3)
18 18 (7.3, 4.4 - 11.4) 7 (10.3, 4.2 - 20.1) 1.4 (0.6-3.3)
45 19 (7.8, 4.7 - 1.8) 4 (5.9, 1.6 - 14.4) 0.8 (0.3-2.2)
35 30 (12.2, 8.4 - 17.0) 4 (5.9, 1.6 - 14.4) 0.5 (0.2-1.3)
56 22 (9.0, 5.1 - 12.3) 4 (5.9, 1.6 - 14.4) 0.7 (0.2-1.9)
51 14 (5.7, 3.2 - 9.4) 3 (4.4, 0.9 - 12.4) 0.8 (0.2-2.7)
31 27 (11.0, 7.4 - 15.6) 1 (1.5, 0.1 - 7.9) 0.1 (0.0-0.7)
33 5 (2.0, 0.7 - 4.7) 1 (1.5, 0.1 - 7.9) 0.7 (0.0-4.1)
39 6 (2.4, 0.9 - 5.3) 1 (1.5, 0.1 - 7.9) 0.6 (0.0-3.4)
73 4 (1.6, 0.4 - 4.1) 1 (1.5, 0.1 - 7.9) 0.9 (0.0-5.2)
52 13 (5.3, 2.9 - 8.9) 0 (0.0, 0.0 - 5.2) 0.0 (0.0-0.99)
58 21 (8.6, 5.4 -12.8) 0 (0.0, 0.0 - 5.2) 0.0 (0.0-0.6)
68 2 (0.8, 0.1 - 2.8) 0 (0.0, 0.0 - 5.2) 0.0 (0.0-6.8)
82 4 (1.6, 0.4 - 4.1)a 0 (0.0, 0.0 - 5.2) 0.0 (0.0-3.4)
Any high-risk 169 (69.0, 62.8 - 74.7) 67 (98.5, 92.1 - 99.9) 1.4 (1.1-1.9)
Any low-risk 110 (44.9, 38.6 - 51.4) 2 (2.9, 0.4 - 10.2) b 0.1 (0.0-0.2)
Any multiple 68 (27.8, 22.2 - 33.8) 5 (7.4, 2.4 - 16.3) c 0.3 (0.1-0.6)
16/18 47 (19.2, 14.4 - 24.7) 53 (77.9, 66.2 - 87.1) 4.1 (2.8-5.8)
16/18/31/33/45 90 (36.7, 30.7 - 43.1) 58 (85.2, 74.6 - 92.7) 2.3 (1.7-3.2)
  1. CI = confidence interval; HPV = human papillomavirus; ICC = invasive cervical cancer
  2. a one woman subsequently confirmed with ICC.b1 ICC was positive for a low-risk type only (HPV30). cIncluding 16/35, 16/45, 16/51, 16/53/56, 16/56, for which the individual types are counted separately.